Clinical Trial Update: Metabolic and Metagenomic Effects of Intestinal Microbiome Repopulation in Unexplained Atherosclerosis [Phase 1]

View source ↗

Summary

Phase 1 trial investigating metabolic and metagenomic effects of intestinal microbiome repopulation in patients with atherosclerosis. The study is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: Western University, Canada | Conditions: Atherosclerosis, Intestinal Microbiome | Phase 1 | Status: RECRUITING